Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures
NCT: NCT04854070 · COMPLETED
Brief Summary
The IVUS CHIP trial is a post-marketing strategy study in which patients with complex coronary lesions, undergoing percutaneous coronary intervention (PCI), are treated either with intravascular ultrasound (IVUS) guided PCI or angiographic guided PCI . The IVUS-guided PCI approach is indicated to reduce the frequency of target-lesion failure (cardiac death, target-vessel myocardial infarction, and clinically indicated target-lesion revascularization) in patients with complex coronary lesions undergoing PCI. The objective of this study is to assess the superiority of an IVUS-guided approach versus an angio-guided approach in patients with complex coronary lesions undergoing PCI.
Frequently Asked Questions
What is Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures?
Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures is a clinical trial registered under NCT04854070. Current status: COMPLETED.
What is the status of NCT04854070?
The current status of NCT04854070 (Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures) is: COMPLETED.
When did Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures start?
Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures started on 2021-11-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.